At @ months , total body bone mineral content and BMD had increased in the norethindrone acetate plus conjugated equine estrogens group ( bone mineral content +@ g , P < @ and BMD +@ g/cm , P = @ ) , but not in those receiving norethindrone acetate plus placebo ( bone mineral content P = @ and BMD P = @ ) .